oral inhibitor Archives

Insilico Medicine Announces Completion of IND-enabling Studies for AI-empowered Oral Inhibitor Aimed at Transformative Parkinson’s Disease Treatment

Insider Brief PRESS RELEASE — Insilico Medicine(“Insilico”), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has completed IND-enabling studies

18 Aug 2025 · 4 min read

Oral inhibitor

Insilico Medicine Announces Completion of IND-enabling Studies for AI-empowered Oral Inhibitor Aimed at Transformative Parkinson’s Disease Treatment

Trending today

Manus Parent Butterfly Effect Closes Over $500M in First Funding Since Collapsed $2B Meta Deal

Anthropic Updates Claude Usage Policy to Bar Model Abuse, Election Interference and Surveillance

Deep Robotics Tests DR02 Humanoids in Hangzhou Traffic and Tourist Areas

UK Backs Robotics Adoption Hubs With £40M in Funding

Melius Secures $25M From CRV and General Catalyst to Build AI Agents for Ad Creative

Oral inhibitor

Insilico Medicine Announces Completion of IND-enabling Studies for AI-empowered Oral Inhibitor Aimed at Transformative Parkinson’s Disease Treatment

Trending today

Manus Parent Butterfly Effect Closes Over $500M in First Funding Since Collapsed $2B Meta Deal

Anthropic Updates Claude Usage Policy to Bar Model Abuse, Election Interference and Surveillance

Deep Robotics Tests DR02 Humanoids in Hangzhou Traffic and Tourist Areas

UK Backs Robotics Adoption Hubs With £40M in Funding

Melius Secures $25M From CRV and General Catalyst to Build AI Agents for Ad Creative

The AI economy, every weekday morning